Profile data is unavailable for this security.
About the company
Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.
- Revenue in PLN (TTM)516.00k
- Net income in PLN-18.79m
- Incorporated2017
- Employees40.00
- LocationScope Fluidics SAul. Ogrodowa 58, 9 pietroWARSZAWA 00-876PolandPOL
- Phone+48 223762114
- Websitehttps://scopefluidics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urteste SA | 0.00 | -5.59m | 132.51m | -- | -- | 4.78 | -- | -- | -4.52 | -4.52 | 0.00 | 19.68 | 0.00 | 3.86 | -- | -- | -30.78 | -- | -32.71 | -- | -- | -- | -- | -- | 17.11 | -- | 0.0221 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
| Sds Optic SA | 530.40k | -7.39m | 134.01m | -- | -- | 19.11 | -- | 252.65 | -1.30 | -1.30 | 0.0928 | 1.19 | 0.054 | -5.91 | 2.11 | -- | -75.38 | -- | -94.39 | -- | 167.64 | -- | -1,395.87 | -- | 4.85 | -- | 0.00 | -- | -99.59 | -- | -85.26 | -- | -- | -- |
| Genomtec SA | 1.00k | -9.01m | 154.45m | -- | -- | 18.60 | -- | 154,449.40 | -0.8037 | -0.8037 | 0.00009 | 0.6773 | 0.00007 | 15.45 | 0.0008 | -- | -65.01 | -- | -80.98 | -- | -81,000.00 | -- | -901,300.00 | -- | 2.11 | -46.67 | 0.1613 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
| Poltreg SA | 1.40m | -13.55m | 219.65m | 23.00 | -- | 2.51 | -- | 157.00 | -2.91 | -2.91 | 0.300 | 18.77 | 0.0112 | 51.22 | 27.43 | 61,494.50 | -10.82 | -6.51 | -12.42 | -7.35 | -811.65 | -391.38 | -968.62 | -449.24 | 3.87 | -- | 0.0856 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| Molecure SA | 1.31m | -18.31m | 246.48m | 111.00 | -- | 1.57 | -- | 188.36 | -1.17 | -1.17 | 0.0847 | 9.34 | 0.0085 | -- | 0.2818 | 11,788.92 | -11.94 | 2.52 | -12.47 | 2.64 | -25.76 | 97.54 | -1,398.86 | 12.84 | -- | -- | 0.0434 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
| Bioceltix SA | 0.00 | -12.73m | 282.46m | -- | -- | 19.85 | -- | -- | -3.45 | -3.45 | 0.00 | 3.45 | 0.00 | 170.52 | -- | -- | -112.58 | -- | -140.07 | -- | -- | -- | -- | -- | 5.96 | -- | 0.0071 | -- | -- | -- | -102.87 | -- | -- | -- |
| Mabion SA | 146.11m | 42.34m | 297.06m | 226.00 | 7.02 | 2.20 | 5.98 | 2.03 | 2.62 | 2.62 | 9.04 | 8.37 | 0.7084 | 4.59 | 8.27 | 646,495.60 | 20.53 | -7.19 | 28.38 | -16.79 | 75.66 | 58.10 | 28.98 | -14.27 | 1.93 | 25.96 | 0.1513 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
| BIOTON SA | 181.64m | 2.28m | 304.82m | 358.00 | 134.01 | 0.5027 | 8.18 | 1.68 | 0.0265 | 0.0265 | 2.12 | 7.06 | 0.2228 | 0.9493 | 18.41 | 507,363.10 | 0.279 | -1.99 | 0.3437 | -2.47 | 40.11 | 45.33 | 1.25 | -8.61 | 0.2933 | 1.90 | 0.1018 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Captor Therapeutics SA | 13.20m | -70.58m | 320.75m | 104.00 | -- | 5.10 | -- | 24.30 | -16.42 | -16.42 | 3.04 | 14.90 | 0.1256 | -- | 3.59 | 126,932.70 | -67.13 | -- | -82.96 | -- | 52.28 | -- | -534.69 | -- | -- | -- | 0.0518 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
| Synthaverse SA | 58.61m | 4.76m | 329.57m | 239.00 | 74.57 | 3.15 | 28.94 | 5.62 | 0.0677 | 0.0677 | 0.8341 | 1.60 | 0.2732 | 1.66 | 2.76 | 245,217.60 | 2.22 | 3.53 | 2.55 | 4.32 | 60.00 | 55.62 | 8.12 | 9.59 | 0.9705 | 4.47 | 0.3834 | -- | 16.32 | 12.66 | -21.76 | -- | 111.77 | -- |
| Scope Fluidics SA | 516.00k | -18.79m | 447.05m | 40.00 | -- | 5.52 | -- | 866.38 | -6.89 | -6.89 | 0.1893 | 29.69 | 0.0023 | 2.73 | 0.1827 | 12,900.00 | -8.39 | 52.74 | -8.61 | 57.32 | -265.89 | -420.87 | -3,640.50 | 30,134.78 | 14.60 | -- | 0.0289 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
| Celon Pharma SA | 216.57m | -28.12m | 859.79m | 513.00 | -- | 1.93 | 30.70 | 3.97 | -0.5508 | -0.5508 | 4.24 | 8.73 | 0.3574 | 2.08 | 7.23 | -- | -4.64 | -2.24 | -5.57 | -2.57 | 68.92 | 70.71 | -12.99 | -7.79 | 1.89 | -- | 0.0543 | -- | 11.29 | 11.57 | 28.40 | -- | -13.42 | -- |
Data as of May 17 2024. Currency figures normalised to Scope Fluidics SA's reporting currency: Polish New Zloty PLN
22.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| IPOPEMA TFI SAas of 29 Jun 2023 | 482.46k | 17.70% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 80.00k | 2.94% |
| TFI PZU SAas of 30 Jun 2023 | 30.50k | 1.12% |
| ESALIENS TFI SAas of 30 Jun 2020 | 10.47k | 0.38% |
| Rockbridge TFIas of 30 Jun 2023 | 1.84k | 0.07% |
More ▼
Data from 30 Jun 2020 - 31 Dec 2023Source: FactSet Research Systems Inc.
